The device called Mint, which would work with the company’s adaptive insulin dosing algorithm, is expected to debut in the ...

The above button links to Coinbase. Yahoo Finance is not a broker-dealer or investment adviser and does not offer securities or cryptocurrencies for sale or facilitate trading. Coinbase pays us for ...

The above button links to Coinbase. Yahoo Finance is not a broker-dealer or investment adviser and does not offer securities or cryptocurrencies for sale or facilitate trading. Coinbase pays us for ...

Beta Bionics, Inc., a leader in diabetes management solutions, announced it will release its first quarter financial results for 2025 on May 6, 2025, after market close. Management will hold a ...

Net sales of $27.6 million, up 57% compared to $17.6 million in the first quarter of 2025. Gross margin of 59.5%, up 864 basis points compared to 50.9% in the first quarter of 2025. New patient starts ...

Beta Bionics’ iLet insulin pump now counts an installed user base of more than 35K Beta Bionics Inc. Chief Executive Sean Saint described the first year of being a public company as a “rollercoaster.” ...

IRVINE, Calif., April 21, 2026 (GLOBE NEWSWIRE)-- Beta Bionics, Inc. (Nasdaq: BBNX), a pioneering leader in the development of advanced diabetes management solutions, today reported its financial ...